Wednesday, June 10, 2026
πŸ‡ΊπŸ‡Έ FDA

biotech Β· Pulmonary Disease, Chronic Obstructive Β· Symptomatic Neurogenic Orthostatic Hypertension Β· TBPH

Theravance Biopharma Ireland

Theravance Biopharma Ireland Umited

Theravance Biopharma Ireland patent portfolio β€” 635 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
901 Gateway Blvd., South San Francisco, CA 94080, US HQ
2014 Founded
177 Employees
Public company Type
TBPH Β· NYSE Ticker
Company details
Status
Public
HQ
901 Gateway Blvd., South San Francisco, CA 94080, US
Founded
2014
Employees
177
Programs
57
Drugs
18
Patents
635
Official website β†— All projects Drug pipeline Patents News & analysis
Intelligence Β· Patents

Theravance Biopharma Ireland patents

635 pharmaceutical patents indexed for Theravance Biopharma Ireland. 56 expire within 24 months.

Theravance Biopharma Ireland has 635 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 56 expire within 24 months β€” use filters for patent-cliff planning.

All patents Expiring ≀12 months Expiring ≀24 months

635 patents

Patent portfolio

Page 10 of 14

  1. US 7855221

    Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

    Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7851467

    Carbamate compounds as 5-HT4 receptor agonists

    Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7851631

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7851632

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7846973

    Chemical process and new crystalline form

    Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7842704

    Compounds having Ξ²2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7838535

    Compounds having Ξ²2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7834185

    Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

    Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7834041

    Dual-acting antihypertensive agents

    Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7829728

    Diarymethyl and related compounds

    Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7829583

    Biphenyl derivatives

    Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7816532

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7803812

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7790766

    Pharmaceutical compositions of short-acting sedative hypnotic agent

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7786136

    Indazole-carboxamide compounds

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7777077

    Dual-acting antihypertensive agents

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7772434

    Crystalline form of a Ξ²2 adrenergic receptor agonist

    Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7772239

    Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists

    Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7772250

    Compounds

    Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7763637

    Quinolinone-carboxamide compounds as 5-HT4, receptor agonists

    Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7759363

    Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists

    Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7732441

    Azabicycloalkane compounds

    Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7728127

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7728004

    Crystalline form of a quinolinone-carboxamide compound

    Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7728104

    Process for preparing glycopeptide phosphonate derivatives

    Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7728006

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7728144

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7723470

    Glycopeptide derivatives and pharmaceutical compositions containing the same

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7713931

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7700550

    Glycopeptide phosphonate derivatives

    Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7700777

    Crystalline forms of a biphenyl compound

    Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7691878

    Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7687519

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7687521

    Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7683173

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7674908

    Indazole-carboxamide compounds as 5-HT4 receptor agonists

    Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7671198

    Process for preparing intermediates to 5-HT4 receptor agonist compounds

    Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7662815

    Diaryl ether Ξ²2 adrenergic receptor agonists

    Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7659403

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7655621

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7649080

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7642355

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7638639

    Substituted pyrrolidine and related compounds

    Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7632847

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7629336

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7622587

    Crystalline form of a benzimidazole-carboxamide medicinal compound

    Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7622467

    Aryl aniline derivatives as Ξ²2 adrenergic receptor agonists

    Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7622508

    8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Theravance Biopharma Ireland have?

635 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Theravance Biopharma Ireland patents expire?

56 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.